Orange, Connecticut, United States Griffin Hospital appeared to be the Corporate Investor, which was created in 1909. The main department of described Corporate Investor is located in the Orange. The company was established in North America in United States.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2017.
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Griffin Hospital, startups are often financed by White Owl Capital Partners, Safeguard Scientifics, Kapor Capital. The meaningful sponsors for the fund in investment in the same round are White Owl Capital Partners, The Children's Hospital of Philadelphia, Sutter Health. In the next rounds fund is usually obtained by Robert Parkinson, Marc Benioff, Intermountain Healthcare.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Velano Vascular.
Related Funds
| Fund Name | Location |
| Digital First Media | Colorado, Denver, United States |
| gmoney NFT | - |
| LIGHTHOUSE | Beijing, Beijing, China |
| Patagonia Capital | - |
| PlanetSpark | Gurgaon, Haryana, India |
| Shunyi Investment | China, Shanghai |
| Smash Ventures | California, Los Angeles, United States |
| TMT Investments | Jersey, NA - Jersey |
| TrustSwap | - |
| Zilkha Venture Partners | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Velano Vascular | $17M | 07 Mar 2017 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Velano Vascular | $17M | 07 Mar 2017 | San Francisco, California, United States |
